{"nct_id":"NCT02513459","title":"A Long Term Extension Trial of BI 655066/ABBV-066 (Risankizumab), in Patients With Moderately to Severely Active Crohn's Disease","status":"COMPLETED","status_verified_date":"2020-04","start_date":"2015-09-16","start_date_type":"ACTUAL","primary_completion_date":"2019-06-19","primary_completion_date_type":"ACTUAL","completion_date":"2019-06-19","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["ABBV"]}